Archemin

Advice & reporting for the chemical and pharmaceutical industries

News & updates

Archemin Delegation present at ISPOR 2013 posted on November 06th 2013 by Inneke Van de Vijver Whereas the development of medicinal products used to be a purely sequential process, consisting of clinical development, registration process followed by a price and reimbursement application and then market launch, this is no longer realistic. Read more	Interactive training session on Belgian Pricing and Reimbursement procedures for medicines posted on October 18th 2013 by Inneke Van de Vijver Archemin's Market Acces Specialists provide interactive trainings on Belgian Pricing and Reimbursement procedures for medicines. These 3-4 hour training sessions focus on Read more
Course on developing and managing a compliant Pharmacovigilance system posted on September 09th 2013 by Ludwig Everaert The Archemin pharmacovigilance team, together with several customers' delegates, benefited from the frist of a very intensive interactive 2- day pharmacovigilance training course. Read more	Belgium to implement the new EU PharmacoVigilance legislation on a local level posted on July 26th 2013 by Tomas Bellemans 28 may 2013 a Royal Decree was published in Belgium regulating the national implementation of the EU PharmacoVigilance legislation. More details on the interpretation of these legal texts by the Federal Agency for Medicines and Healthcare Products (FAMHP) can be found in 2 new circular letters. In summary: Read more
Pharmacovigilance - Introducing a black symbol to identify Medicinal Products subject to additional monitoring. posted on March 08th 2013 by Tomas Bellemans To identify medicinal products that are subject to additional monitoring, the EU Commission adopted an implementing Regulation (198/2013) introducing a black symbol on the 7th of March. Read more	Free samples - Medicines for Human Use posted on December 19th 2012 by Helena Van Overloop The Belgian Federal Agency for Medicines and Medicinal Products reminds pharmaceutical companies that samples can only be provided to prescribers upon presentation of a written request that strictly complies with the legal requirements. (circular letter number 594 dd 18 december 2012). Read more
Financing LOKs / GLEMs (Local Quality Circles) posted on December 10th 2012 by Helena Van Overloop Physicians are required to continuously update their professional knowledge and regular meetings of multidisciplinary Local Quality Circles (LOKs / GLEMs) have become an essential tool to promote the quality of Belgian Health Care. Read more	Development of your Pharmacovigilance Quality System posted on October 30th 2012 by Tomas Bellemans Even though the rules on pharmacovigilance have been improved in 2010, potential weaknesses were brought to light in 2011. Therefore, the Commission proposed extensive additional amendments to the legislation. Parts of the new EU legislation already entered into force in July 2012 and are now being transposed in national legislation. Read more
Approval of medical information: guidelines Mdeon posted on October 09th 2012 by Helena Van Overloop The Federal Agency of Medicines and Health Products (FAMHP) has approved a short guidance document on promotional activities by the pharmaceutical industry. This document, prepared by Mdeon covers premiums and benefits for healthcare professionals as well as scientific activities that do not require an Mdeon visum. Read more	Archemin accredited as advisor for "Strategic Entrepreneurship" posted on August 21st 2012 by Ludwig Everaert Archemin has been accredited as advisor for "Strategic Entrepreneurship" by the Enterprise Flanders (Agentschap Ondernemen), a government agency, charged with the economy and enterprise policy in Flanders, the Dutch speaking northern part of Belgium. Read more

Pages